Pharma Wants Clarity On Joint Evaluation Of EU Paediatric And Orphan Regulations
Executive Summary
The European Commission's plans to evaluate the EU pediatric and orphan drugs regulation in tandem has prompted questions from the pharmaceutical industry on how exactly this critical exercise would proceed and what its ultimate objective would be.